Sector ratings Merck & Co., Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 11:54:31 2026-06-16 EDT			5-day change	1st Jan Change
115.00 ^USD	+0.09%		-4.13%	+8.93%

09:08am	Merck Signs Drug Discovery, Licensing Deal With Protillion Biosciences	MT
08:39am	Moderna announces executive changes ahead of potential launches	RE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
MERCK & CO., INC.	284B		A
MERCK KGAA	66.94B		AAA
HALOZYME THERAPEUTICS, INC.	8.45B		BBB
KYOWA KIRIN CO., LTD.	7.81B		AA
SK BIOPHARMACEUTICALS CO., LTD.	4.67B		AAA
YUHAN CORPORATION	3.89B		AA
BETTA PHARMACEUTICALS CO., LTD.	3.32B		-			-
SUPERNUS PHARMACEUTICALS, INC.	2.55B	-	BB	-		-
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	1.99B	-	-	-	-	-	-	-
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	1.7B	-	-	-		-	-	-
SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.	1.67B	-	-	-		-	-
VELOXIS PHARMACEUTICALS A/S	1.64B	-	-	-	-	-	-	-
MEZZION PHARMA CO.,LTD.	1.28B	-	BBB	-	-	-	-	-
SHANGHAI YIZHONG PHARMACEUTICAL CO., LTD.	1.23B	-	-	-	-	-	-	-
DBV TECHNOLOGIES	1.09B	-	-	-		-
FRONTIER BIOTECHNOLOGIES INC.	988M	-	-	-	-	-	-	-
KISSEI PHARMACEUTICAL CO., LTD.	1.02B		BBB
OSCOTEC INC.	993M		CCC				-
CHANGCHUN BCHT BIOTECHNOLOGY CO.	873M		-			-	-
YOUCARE PHARMACEUTICAL GROUP CO., LTD.	880M	-	-	-		-	-	-
Average	19.84B		A
Weighted average by Cap.			A